Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 112

Published Date: 26 Aug 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

According to our (Global Info Research) latest study, the global RNA Modified Pseudouridine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global RNA Modified Pseudouridine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global RNA Modified Pseudouridine market size and forecasts, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Modified Pseudouridine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Modified Pseudouridine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
RNA Modified Pseudouridine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
RNA Modified Pseudouridine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Solution
Powder

Market segment by Application
mRNA Vaccines
Gene Expression and Therapy
Other

Market segment by players, this report covers
YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNA Modified Pseudouridine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNA Modified Pseudouridine, with revenue, gross margin, and global market share of RNA Modified Pseudouridine from 2019 to 2024.
Chapter 3, the RNA Modified Pseudouridine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNA Modified Pseudouridine market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Modified Pseudouridine.
Chapter 13, to describe RNA Modified Pseudouridine research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNA Modified Pseudouridine by Type
1.3.1 Overview: Global RNA Modified Pseudouridine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global RNA Modified Pseudouridine Consumption Value Market Share by Type in 2023
1.3.3 Solution
1.3.4 Powder
1.4 Global RNA Modified Pseudouridine Market by Application
1.4.1 Overview: Global RNA Modified Pseudouridine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 mRNA Vaccines
1.4.3 Gene Expression and Therapy
1.4.4 Other
1.5 Global RNA Modified Pseudouridine Market Size & Forecast
1.6 Global RNA Modified Pseudouridine Market Size and Forecast by Region
1.6.1 Global RNA Modified Pseudouridine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global RNA Modified Pseudouridine Market Size by Region, (2019-2030)
1.6.3 North America RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.4 Europe RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.6 South America RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa RNA Modified Pseudouridine Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 YAMASA CORPORATION
2.1.1 YAMASA CORPORATION Details
2.1.2 YAMASA CORPORATION Major Business
2.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Product and Solutions
2.1.4 YAMASA CORPORATION RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 YAMASA CORPORATION Recent Developments and Future Plans
2.2 Biosynth Carbosynth
2.2.1 Biosynth Carbosynth Details
2.2.2 Biosynth Carbosynth Major Business
2.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Product and Solutions
2.2.4 Biosynth Carbosynth RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biosynth Carbosynth Recent Developments and Future Plans
2.3 TriLink BioTechnologies
2.3.1 TriLink BioTechnologies Details
2.3.2 TriLink BioTechnologies Major Business
2.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Product and Solutions
2.3.4 TriLink BioTechnologies RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TriLink BioTechnologies Recent Developments and Future Plans
2.4 MP Biomedicals, Inc
2.4.1 MP Biomedicals, Inc Details
2.4.2 MP Biomedicals, Inc Major Business
2.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Product and Solutions
2.4.4 MP Biomedicals, Inc RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MP Biomedicals, Inc Recent Developments and Future Plans
2.5 Thermo Scientific Chemicals
2.5.1 Thermo Scientific Chemicals Details
2.5.2 Thermo Scientific Chemicals Major Business
2.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Solutions
2.5.4 Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Thermo Scientific Chemicals Recent Developments and Future Plans
2.6 BOC Sciences
2.6.1 BOC Sciences Details
2.6.2 BOC Sciences Major Business
2.6.3 BOC Sciences RNA Modified Pseudouridine Product and Solutions
2.6.4 BOC Sciences RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BOC Sciences Recent Developments and Future Plans
2.7 Toronto Research Chemical
2.7.1 Toronto Research Chemical Details
2.7.2 Toronto Research Chemical Major Business
2.7.3 Toronto Research Chemical RNA Modified Pseudouridine Product and Solutions
2.7.4 Toronto Research Chemical RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Toronto Research Chemical Recent Developments and Future Plans
2.8 Wuhan Glycogene
2.8.1 Wuhan Glycogene Details
2.8.2 Wuhan Glycogene Major Business
2.8.3 Wuhan Glycogene RNA Modified Pseudouridine Product and Solutions
2.8.4 Wuhan Glycogene RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Wuhan Glycogene Recent Developments and Future Plans
2.9 Fine Biotech
2.9.1 Fine Biotech Details
2.9.2 Fine Biotech Major Business
2.9.3 Fine Biotech RNA Modified Pseudouridine Product and Solutions
2.9.4 Fine Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Fine Biotech Recent Developments and Future Plans
2.10 Shanghai Hongene Biotech
2.10.1 Shanghai Hongene Biotech Details
2.10.2 Shanghai Hongene Biotech Major Business
2.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Solutions
2.10.4 Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Hongene Biotech Recent Developments and Future Plans
2.11 Biori
2.11.1 Biori Details
2.11.2 Biori Major Business
2.11.3 Biori RNA Modified Pseudouridine Product and Solutions
2.11.4 Biori RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Biori Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global RNA Modified Pseudouridine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of RNA Modified Pseudouridine by Company Revenue
3.2.2 Top 3 RNA Modified Pseudouridine Players Market Share in 2023
3.2.3 Top 6 RNA Modified Pseudouridine Players Market Share in 2023
3.3 RNA Modified Pseudouridine Market: Overall Company Footprint Analysis
3.3.1 RNA Modified Pseudouridine Market: Region Footprint
3.3.2 RNA Modified Pseudouridine Market: Company Product Type Footprint
3.3.3 RNA Modified Pseudouridine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global RNA Modified Pseudouridine Consumption Value and Market Share by Type (2019-2024)
4.2 Global RNA Modified Pseudouridine Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2024)
5.2 Global RNA Modified Pseudouridine Market Forecast by Application (2025-2030)

6 North America
6.1 North America RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
6.2 North America RNA Modified Pseudouridine Market Size by Application (2019-2030)
6.3 North America RNA Modified Pseudouridine Market Size by Country
6.3.1 North America RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
6.3.2 United States RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
6.3.3 Canada RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
6.3.4 Mexico RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
7.2 Europe RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
7.3 Europe RNA Modified Pseudouridine Market Size by Country
7.3.1 Europe RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
7.3.2 Germany RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.3 France RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.5 Russia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.6 Italy RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific RNA Modified Pseudouridine Market Size by Region
8.3.1 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2019-2030)
8.3.2 China RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.3 Japan RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.4 South Korea RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.5 India RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.7 Australia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

9 South America
9.1 South America RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
9.2 South America RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
9.3 South America RNA Modified Pseudouridine Market Size by Country
9.3.1 South America RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
9.3.2 Brazil RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
9.3.3 Argentina RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa RNA Modified Pseudouridine Market Size by Country
10.3.1 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
10.3.2 Turkey RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
10.3.4 UAE RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 RNA Modified Pseudouridine Market Drivers
11.2 RNA Modified Pseudouridine Market Restraints
11.3 RNA Modified Pseudouridine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 RNA Modified Pseudouridine Industry Chain
12.2 RNA Modified Pseudouridine Upstream Analysis
12.3 RNA Modified Pseudouridine Midstream Analysis
12.4 RNA Modified Pseudouridine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global RNA Modified Pseudouridine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global RNA Modified Pseudouridine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global RNA Modified Pseudouridine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global RNA Modified Pseudouridine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. YAMASA CORPORATION Company Information, Head Office, and Major Competitors
Table 6. YAMASA CORPORATION Major Business
Table 7. YAMASA CORPORATION RNA Modified Pseudouridine Product and Solutions
Table 8. YAMASA CORPORATION RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. YAMASA CORPORATION Recent Developments and Future Plans
Table 10. Biosynth Carbosynth Company Information, Head Office, and Major Competitors
Table 11. Biosynth Carbosynth Major Business
Table 12. Biosynth Carbosynth RNA Modified Pseudouridine Product and Solutions
Table 13. Biosynth Carbosynth RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biosynth Carbosynth Recent Developments and Future Plans
Table 15. TriLink BioTechnologies Company Information, Head Office, and Major Competitors
Table 16. TriLink BioTechnologies Major Business
Table 17. TriLink BioTechnologies RNA Modified Pseudouridine Product and Solutions
Table 18. TriLink BioTechnologies RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. MP Biomedicals, Inc Company Information, Head Office, and Major Competitors
Table 20. MP Biomedicals, Inc Major Business
Table 21. MP Biomedicals, Inc RNA Modified Pseudouridine Product and Solutions
Table 22. MP Biomedicals, Inc RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. MP Biomedicals, Inc Recent Developments and Future Plans
Table 24. Thermo Scientific Chemicals Company Information, Head Office, and Major Competitors
Table 25. Thermo Scientific Chemicals Major Business
Table 26. Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Solutions
Table 27. Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Thermo Scientific Chemicals Recent Developments and Future Plans
Table 29. BOC Sciences Company Information, Head Office, and Major Competitors
Table 30. BOC Sciences Major Business
Table 31. BOC Sciences RNA Modified Pseudouridine Product and Solutions
Table 32. BOC Sciences RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. BOC Sciences Recent Developments and Future Plans
Table 34. Toronto Research Chemical Company Information, Head Office, and Major Competitors
Table 35. Toronto Research Chemical Major Business
Table 36. Toronto Research Chemical RNA Modified Pseudouridine Product and Solutions
Table 37. Toronto Research Chemical RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Toronto Research Chemical Recent Developments and Future Plans
Table 39. Wuhan Glycogene Company Information, Head Office, and Major Competitors
Table 40. Wuhan Glycogene Major Business
Table 41. Wuhan Glycogene RNA Modified Pseudouridine Product and Solutions
Table 42. Wuhan Glycogene RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Wuhan Glycogene Recent Developments and Future Plans
Table 44. Fine Biotech Company Information, Head Office, and Major Competitors
Table 45. Fine Biotech Major Business
Table 46. Fine Biotech RNA Modified Pseudouridine Product and Solutions
Table 47. Fine Biotech RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Fine Biotech Recent Developments and Future Plans
Table 49. Shanghai Hongene Biotech Company Information, Head Office, and Major Competitors
Table 50. Shanghai Hongene Biotech Major Business
Table 51. Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Solutions
Table 52. Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Shanghai Hongene Biotech Recent Developments and Future Plans
Table 54. Biori Company Information, Head Office, and Major Competitors
Table 55. Biori Major Business
Table 56. Biori RNA Modified Pseudouridine Product and Solutions
Table 57. Biori RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Biori Recent Developments and Future Plans
Table 59. Global RNA Modified Pseudouridine Revenue (USD Million) by Players (2019-2024)
Table 60. Global RNA Modified Pseudouridine Revenue Share by Players (2019-2024)
Table 61. Breakdown of RNA Modified Pseudouridine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in RNA Modified Pseudouridine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 63. Head Office of Key RNA Modified Pseudouridine Players
Table 64. RNA Modified Pseudouridine Market: Company Product Type Footprint
Table 65. RNA Modified Pseudouridine Market: Company Product Application Footprint
Table 66. RNA Modified Pseudouridine New Market Entrants and Barriers to Market Entry
Table 67. RNA Modified Pseudouridine Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global RNA Modified Pseudouridine Consumption Value (USD Million) by Type (2019-2024)
Table 69. Global RNA Modified Pseudouridine Consumption Value Share by Type (2019-2024)
Table 70. Global RNA Modified Pseudouridine Consumption Value Forecast by Type (2025-2030)
Table 71. Global RNA Modified Pseudouridine Consumption Value by Application (2019-2024)
Table 72. Global RNA Modified Pseudouridine Consumption Value Forecast by Application (2025-2030)
Table 73. North America RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 74. North America RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 75. North America RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 76. North America RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 77. North America RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 78. North America RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Europe RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 80. Europe RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 81. Europe RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Europe RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Europe RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 84. Europe RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2025-2030) & (USD Million)
Table 91. South America RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 92. South America RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 93. South America RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 94. South America RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 95. South America RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 98. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 99. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 100. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 101. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Global Key Players of RNA Modified Pseudouridine Upstream (Raw Materials)
Table 104. Global RNA Modified Pseudouridine Typical Customers


List of Figures
Figure 1. RNA Modified Pseudouridine Picture
Figure 2. Global RNA Modified Pseudouridine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global RNA Modified Pseudouridine Consumption Value Market Share by Type in 2023
Figure 4. Solution
Figure 5. Powder
Figure 6. Global RNA Modified Pseudouridine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. RNA Modified Pseudouridine Consumption Value Market Share by Application in 2023
Figure 8. mRNA Vaccines Picture
Figure 9. Gene Expression and Therapy Picture
Figure 10. Other Picture
Figure 11. Global RNA Modified Pseudouridine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global RNA Modified Pseudouridine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market RNA Modified Pseudouridine Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 14. Global RNA Modified Pseudouridine Consumption Value Market Share by Region (2019-2030)
Figure 15. Global RNA Modified Pseudouridine Consumption Value Market Share by Region in 2023
Figure 16. North America RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 19. South America RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East & Africa RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global RNA Modified Pseudouridine Revenue Share by Players in 2023
Figure 23. RNA Modified Pseudouridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 24. Market Share of RNA Modified Pseudouridine by Player Revenue in 2023
Figure 25. Top 3 RNA Modified Pseudouridine Players Market Share in 2023
Figure 26. Top 6 RNA Modified Pseudouridine Players Market Share in 2023
Figure 27. Global RNA Modified Pseudouridine Consumption Value Share by Type (2019-2024)
Figure 28. Global RNA Modified Pseudouridine Market Share Forecast by Type (2025-2030)
Figure 29. Global RNA Modified Pseudouridine Consumption Value Share by Application (2019-2024)
Figure 30. Global RNA Modified Pseudouridine Market Share Forecast by Application (2025-2030)
Figure 31. North America RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 32. North America RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 33. North America RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 34. United States RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 41. France RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Region (2019-2030)
Figure 48. China RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 51. India RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 54. South America RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 55. South America RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 56. South America RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 65. RNA Modified Pseudouridine Market Drivers
Figure 66. RNA Modified Pseudouridine Market Restraints
Figure 67. RNA Modified Pseudouridine Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. RNA Modified Pseudouridine Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 112

Published Date: 26 Aug 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

According to our (Global Info Research) latest study, the global RNA Modified Pseudouridine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global RNA Modified Pseudouridine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global RNA Modified Pseudouridine market size and forecasts, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global RNA Modified Pseudouridine market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Modified Pseudouridine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Modified Pseudouridine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
RNA Modified Pseudouridine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
RNA Modified Pseudouridine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Solution
Powder

Market segment by Application
mRNA Vaccines
Gene Expression and Therapy
Other

Market segment by players, this report covers
YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNA Modified Pseudouridine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNA Modified Pseudouridine, with revenue, gross margin, and global market share of RNA Modified Pseudouridine from 2019 to 2024.
Chapter 3, the RNA Modified Pseudouridine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNA Modified Pseudouridine market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Modified Pseudouridine.
Chapter 13, to describe RNA Modified Pseudouridine research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNA Modified Pseudouridine by Type
1.3.1 Overview: Global RNA Modified Pseudouridine Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global RNA Modified Pseudouridine Consumption Value Market Share by Type in 2023
1.3.3 Solution
1.3.4 Powder
1.4 Global RNA Modified Pseudouridine Market by Application
1.4.1 Overview: Global RNA Modified Pseudouridine Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 mRNA Vaccines
1.4.3 Gene Expression and Therapy
1.4.4 Other
1.5 Global RNA Modified Pseudouridine Market Size & Forecast
1.6 Global RNA Modified Pseudouridine Market Size and Forecast by Region
1.6.1 Global RNA Modified Pseudouridine Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global RNA Modified Pseudouridine Market Size by Region, (2019-2030)
1.6.3 North America RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.4 Europe RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.6 South America RNA Modified Pseudouridine Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa RNA Modified Pseudouridine Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 YAMASA CORPORATION
2.1.1 YAMASA CORPORATION Details
2.1.2 YAMASA CORPORATION Major Business
2.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Product and Solutions
2.1.4 YAMASA CORPORATION RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 YAMASA CORPORATION Recent Developments and Future Plans
2.2 Biosynth Carbosynth
2.2.1 Biosynth Carbosynth Details
2.2.2 Biosynth Carbosynth Major Business
2.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Product and Solutions
2.2.4 Biosynth Carbosynth RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biosynth Carbosynth Recent Developments and Future Plans
2.3 TriLink BioTechnologies
2.3.1 TriLink BioTechnologies Details
2.3.2 TriLink BioTechnologies Major Business
2.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Product and Solutions
2.3.4 TriLink BioTechnologies RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TriLink BioTechnologies Recent Developments and Future Plans
2.4 MP Biomedicals, Inc
2.4.1 MP Biomedicals, Inc Details
2.4.2 MP Biomedicals, Inc Major Business
2.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Product and Solutions
2.4.4 MP Biomedicals, Inc RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MP Biomedicals, Inc Recent Developments and Future Plans
2.5 Thermo Scientific Chemicals
2.5.1 Thermo Scientific Chemicals Details
2.5.2 Thermo Scientific Chemicals Major Business
2.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Solutions
2.5.4 Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Thermo Scientific Chemicals Recent Developments and Future Plans
2.6 BOC Sciences
2.6.1 BOC Sciences Details
2.6.2 BOC Sciences Major Business
2.6.3 BOC Sciences RNA Modified Pseudouridine Product and Solutions
2.6.4 BOC Sciences RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BOC Sciences Recent Developments and Future Plans
2.7 Toronto Research Chemical
2.7.1 Toronto Research Chemical Details
2.7.2 Toronto Research Chemical Major Business
2.7.3 Toronto Research Chemical RNA Modified Pseudouridine Product and Solutions
2.7.4 Toronto Research Chemical RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Toronto Research Chemical Recent Developments and Future Plans
2.8 Wuhan Glycogene
2.8.1 Wuhan Glycogene Details
2.8.2 Wuhan Glycogene Major Business
2.8.3 Wuhan Glycogene RNA Modified Pseudouridine Product and Solutions
2.8.4 Wuhan Glycogene RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Wuhan Glycogene Recent Developments and Future Plans
2.9 Fine Biotech
2.9.1 Fine Biotech Details
2.9.2 Fine Biotech Major Business
2.9.3 Fine Biotech RNA Modified Pseudouridine Product and Solutions
2.9.4 Fine Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Fine Biotech Recent Developments and Future Plans
2.10 Shanghai Hongene Biotech
2.10.1 Shanghai Hongene Biotech Details
2.10.2 Shanghai Hongene Biotech Major Business
2.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Solutions
2.10.4 Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Hongene Biotech Recent Developments and Future Plans
2.11 Biori
2.11.1 Biori Details
2.11.2 Biori Major Business
2.11.3 Biori RNA Modified Pseudouridine Product and Solutions
2.11.4 Biori RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Biori Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global RNA Modified Pseudouridine Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of RNA Modified Pseudouridine by Company Revenue
3.2.2 Top 3 RNA Modified Pseudouridine Players Market Share in 2023
3.2.3 Top 6 RNA Modified Pseudouridine Players Market Share in 2023
3.3 RNA Modified Pseudouridine Market: Overall Company Footprint Analysis
3.3.1 RNA Modified Pseudouridine Market: Region Footprint
3.3.2 RNA Modified Pseudouridine Market: Company Product Type Footprint
3.3.3 RNA Modified Pseudouridine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global RNA Modified Pseudouridine Consumption Value and Market Share by Type (2019-2024)
4.2 Global RNA Modified Pseudouridine Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2024)
5.2 Global RNA Modified Pseudouridine Market Forecast by Application (2025-2030)

6 North America
6.1 North America RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
6.2 North America RNA Modified Pseudouridine Market Size by Application (2019-2030)
6.3 North America RNA Modified Pseudouridine Market Size by Country
6.3.1 North America RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
6.3.2 United States RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
6.3.3 Canada RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
6.3.4 Mexico RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
7.2 Europe RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
7.3 Europe RNA Modified Pseudouridine Market Size by Country
7.3.1 Europe RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
7.3.2 Germany RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.3 France RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.4 United Kingdom RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.5 Russia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
7.3.6 Italy RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific RNA Modified Pseudouridine Market Size by Region
8.3.1 Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2019-2030)
8.3.2 China RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.3 Japan RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.4 South Korea RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.5 India RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
8.3.7 Australia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

9 South America
9.1 South America RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
9.2 South America RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
9.3 South America RNA Modified Pseudouridine Market Size by Country
9.3.1 South America RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
9.3.2 Brazil RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
9.3.3 Argentina RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa RNA Modified Pseudouridine Market Size by Country
10.3.1 Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2019-2030)
10.3.2 Turkey RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia RNA Modified Pseudouridine Market Size and Forecast (2019-2030)
10.3.4 UAE RNA Modified Pseudouridine Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 RNA Modified Pseudouridine Market Drivers
11.2 RNA Modified Pseudouridine Market Restraints
11.3 RNA Modified Pseudouridine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 RNA Modified Pseudouridine Industry Chain
12.2 RNA Modified Pseudouridine Upstream Analysis
12.3 RNA Modified Pseudouridine Midstream Analysis
12.4 RNA Modified Pseudouridine Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global RNA Modified Pseudouridine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global RNA Modified Pseudouridine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global RNA Modified Pseudouridine Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global RNA Modified Pseudouridine Consumption Value by Region (2025-2030) & (USD Million)
Table 5. YAMASA CORPORATION Company Information, Head Office, and Major Competitors
Table 6. YAMASA CORPORATION Major Business
Table 7. YAMASA CORPORATION RNA Modified Pseudouridine Product and Solutions
Table 8. YAMASA CORPORATION RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. YAMASA CORPORATION Recent Developments and Future Plans
Table 10. Biosynth Carbosynth Company Information, Head Office, and Major Competitors
Table 11. Biosynth Carbosynth Major Business
Table 12. Biosynth Carbosynth RNA Modified Pseudouridine Product and Solutions
Table 13. Biosynth Carbosynth RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Biosynth Carbosynth Recent Developments and Future Plans
Table 15. TriLink BioTechnologies Company Information, Head Office, and Major Competitors
Table 16. TriLink BioTechnologies Major Business
Table 17. TriLink BioTechnologies RNA Modified Pseudouridine Product and Solutions
Table 18. TriLink BioTechnologies RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. MP Biomedicals, Inc Company Information, Head Office, and Major Competitors
Table 20. MP Biomedicals, Inc Major Business
Table 21. MP Biomedicals, Inc RNA Modified Pseudouridine Product and Solutions
Table 22. MP Biomedicals, Inc RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. MP Biomedicals, Inc Recent Developments and Future Plans
Table 24. Thermo Scientific Chemicals Company Information, Head Office, and Major Competitors
Table 25. Thermo Scientific Chemicals Major Business
Table 26. Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Solutions
Table 27. Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Thermo Scientific Chemicals Recent Developments and Future Plans
Table 29. BOC Sciences Company Information, Head Office, and Major Competitors
Table 30. BOC Sciences Major Business
Table 31. BOC Sciences RNA Modified Pseudouridine Product and Solutions
Table 32. BOC Sciences RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. BOC Sciences Recent Developments and Future Plans
Table 34. Toronto Research Chemical Company Information, Head Office, and Major Competitors
Table 35. Toronto Research Chemical Major Business
Table 36. Toronto Research Chemical RNA Modified Pseudouridine Product and Solutions
Table 37. Toronto Research Chemical RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Toronto Research Chemical Recent Developments and Future Plans
Table 39. Wuhan Glycogene Company Information, Head Office, and Major Competitors
Table 40. Wuhan Glycogene Major Business
Table 41. Wuhan Glycogene RNA Modified Pseudouridine Product and Solutions
Table 42. Wuhan Glycogene RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. Wuhan Glycogene Recent Developments and Future Plans
Table 44. Fine Biotech Company Information, Head Office, and Major Competitors
Table 45. Fine Biotech Major Business
Table 46. Fine Biotech RNA Modified Pseudouridine Product and Solutions
Table 47. Fine Biotech RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Fine Biotech Recent Developments and Future Plans
Table 49. Shanghai Hongene Biotech Company Information, Head Office, and Major Competitors
Table 50. Shanghai Hongene Biotech Major Business
Table 51. Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Solutions
Table 52. Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Shanghai Hongene Biotech Recent Developments and Future Plans
Table 54. Biori Company Information, Head Office, and Major Competitors
Table 55. Biori Major Business
Table 56. Biori RNA Modified Pseudouridine Product and Solutions
Table 57. Biori RNA Modified Pseudouridine Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. Biori Recent Developments and Future Plans
Table 59. Global RNA Modified Pseudouridine Revenue (USD Million) by Players (2019-2024)
Table 60. Global RNA Modified Pseudouridine Revenue Share by Players (2019-2024)
Table 61. Breakdown of RNA Modified Pseudouridine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in RNA Modified Pseudouridine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 63. Head Office of Key RNA Modified Pseudouridine Players
Table 64. RNA Modified Pseudouridine Market: Company Product Type Footprint
Table 65. RNA Modified Pseudouridine Market: Company Product Application Footprint
Table 66. RNA Modified Pseudouridine New Market Entrants and Barriers to Market Entry
Table 67. RNA Modified Pseudouridine Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global RNA Modified Pseudouridine Consumption Value (USD Million) by Type (2019-2024)
Table 69. Global RNA Modified Pseudouridine Consumption Value Share by Type (2019-2024)
Table 70. Global RNA Modified Pseudouridine Consumption Value Forecast by Type (2025-2030)
Table 71. Global RNA Modified Pseudouridine Consumption Value by Application (2019-2024)
Table 72. Global RNA Modified Pseudouridine Consumption Value Forecast by Application (2025-2030)
Table 73. North America RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 74. North America RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 75. North America RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 76. North America RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 77. North America RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 78. North America RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 79. Europe RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 80. Europe RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 81. Europe RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Europe RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Europe RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 84. Europe RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2019-2024) & (USD Million)
Table 90. Asia-Pacific RNA Modified Pseudouridine Consumption Value by Region (2025-2030) & (USD Million)
Table 91. South America RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 92. South America RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 93. South America RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 94. South America RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 95. South America RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 96. South America RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2019-2024) & (USD Million)
Table 98. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Type (2025-2030) & (USD Million)
Table 99. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2019-2024) & (USD Million)
Table 100. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Application (2025-2030) & (USD Million)
Table 101. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2019-2024) & (USD Million)
Table 102. Middle East & Africa RNA Modified Pseudouridine Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Global Key Players of RNA Modified Pseudouridine Upstream (Raw Materials)
Table 104. Global RNA Modified Pseudouridine Typical Customers


List of Figures
Figure 1. RNA Modified Pseudouridine Picture
Figure 2. Global RNA Modified Pseudouridine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global RNA Modified Pseudouridine Consumption Value Market Share by Type in 2023
Figure 4. Solution
Figure 5. Powder
Figure 6. Global RNA Modified Pseudouridine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. RNA Modified Pseudouridine Consumption Value Market Share by Application in 2023
Figure 8. mRNA Vaccines Picture
Figure 9. Gene Expression and Therapy Picture
Figure 10. Other Picture
Figure 11. Global RNA Modified Pseudouridine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global RNA Modified Pseudouridine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market RNA Modified Pseudouridine Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 14. Global RNA Modified Pseudouridine Consumption Value Market Share by Region (2019-2030)
Figure 15. Global RNA Modified Pseudouridine Consumption Value Market Share by Region in 2023
Figure 16. North America RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 19. South America RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East & Africa RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global RNA Modified Pseudouridine Revenue Share by Players in 2023
Figure 23. RNA Modified Pseudouridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 24. Market Share of RNA Modified Pseudouridine by Player Revenue in 2023
Figure 25. Top 3 RNA Modified Pseudouridine Players Market Share in 2023
Figure 26. Top 6 RNA Modified Pseudouridine Players Market Share in 2023
Figure 27. Global RNA Modified Pseudouridine Consumption Value Share by Type (2019-2024)
Figure 28. Global RNA Modified Pseudouridine Market Share Forecast by Type (2025-2030)
Figure 29. Global RNA Modified Pseudouridine Consumption Value Share by Application (2019-2024)
Figure 30. Global RNA Modified Pseudouridine Market Share Forecast by Application (2025-2030)
Figure 31. North America RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 32. North America RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 33. North America RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 34. United States RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 41. France RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific RNA Modified Pseudouridine Consumption Value Market Share by Region (2019-2030)
Figure 48. China RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 51. India RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 54. South America RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 55. South America RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 56. South America RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East & Africa RNA Modified Pseudouridine Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
Figure 65. RNA Modified Pseudouridine Market Drivers
Figure 66. RNA Modified Pseudouridine Market Restraints
Figure 67. RNA Modified Pseudouridine Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. RNA Modified Pseudouridine Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori
jiaGou

Add To Cart

gouMai

Buy Now